Related Experiment Video
Updated: Feb 20, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Primary HPV testing recommendations of US providers, 2015
Crystale Purvis Cooper1, Mona Saraiya2
1Soltera Center for Cancer Prevention and Control, Tucson, AZ 85704, United States.
Many US physicians recommend primary HPV testing for cervical cancer screening, even for younger women. Patient HPV vaccination status significantly influences these recommendations, potentially impacting future screening practices.
Area of Science:
- Gynecology
- Oncology
- Public Health
Background:
- Cervical cancer screening guidelines recommend specific age criteria for primary HPV testing.
- Physician adherence to these guidelines is crucial for effective screening strategies.
Purpose of the Study:
- To investigate the HPV testing recommendations of US physicians performing cervical cancer screening.
- To identify provider characteristics associated with recommending primary HPV testing.
Main Methods:
- Analysis of 2015 DocStyles survey data from 843 US primary care physicians and obstetrician-gynecologists.
- Multivariate logistic regression used to identify factors influencing primary HPV testing recommendations.
Main Results:
- 40.8% of physicians recommended primary HPV testing for average-risk women aged ≥30.
- 90.1% of those recommending primary HPV testing did so for all ages.
- Physicians considering patient HPV vaccination status were nearly 4x more likely to recommend primary HPV testing.
Conclusions:
- A significant number of US physicians recommend primary HPV testing broadly, deviating from current guidelines.
- Patient HPV vaccination status is a key factor influencing physician recommendations for primary HPV testing.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Preventive Healthcare Services
Standards of Care II
Standards of Care I